Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Clears Rapid Blood Test for Mild Traumatic Brain Injury
Use of Direct Acting Antivirals With Potent Inducers Examined in Case Series
Mirabegron Granted Priority Review for Neurogenic Detrusor Overactivity
Jury Awards Huge Verdict After Physician Fails to Diagnose Rare Disorder
Xeomin Approved for Pediatric Patients With Chronic Sialorrhea
New Guidelines for the Management of Lyme Disease
FDA Approves Shorter Infusion Time for MS Drug Ocrevus
Pet Meds Listed in Owner’s Medication Profile Lead to Confusion in the ED
Additional Administration Option Approved for Nuplazid Capsules
Anticholinergics Linked to Increased Dementia Risk
RSNA: Neurologic Complications of COVID-19 Examined
Trehalose Designated Orphan Drug for ALS
Vimpat Approved for Primary Generalized Tonic-Clonic Seizures
FDA Panel Votes on Aducanumab for Alzheimer Disease
Room Temperature Stable Fosphenytoin Gets FDA Approval
Nerivio Device Cleared for Use in Patients With Chronic Migraine
Investigational Drug May Prolong Survival in Patients With ALS
Type of Anesthesia Not Linked to Dementia Risk in Older Adults
